RANCHO CORDOVA, CA, September 2008 – DHR International is pleased to announce the placement of Moni Shavit as Vice President, Research and Development at ThermoGenesis Corp. (Nasdaq: KOOL). Mr. Shavit is relocating from Israel to the United States for the role.
John Baker, Executive Vice President and Global Life Sciences Practice Leader led the search, with assistance from Jeff Goodell, Senior Associate.
Mr. Shavit most recently served as the Vice President of Product Development for Trig Medical, Inc. in Haifa, Israel. In this position he was responsible for oversight and management of the company’s technologies, R&D department, customer support, clinical trials and regulations. Mr. Shavit has more than 20 years of product development and R&D experience. He holds a BS and MS in Electrical Engineering (Bio-Medical and Signal Processing) from the Polytechnic University of New York.
ThermoGenesis Corp.’s Chief Executive, Dr. William Osgood states, “We are extremely pleased with the placement of Moni to our R&D team. His knowledge of the market and depth of experience are extremely relevant to ThermoGenesis. DHR International and specifically, John Baker played a critical role in the entire process.”
ThermoGenesis Corp. (Nasdaq: KOOL) is a growing company that develops and manufactures product platforms that enable the processing and cryopreservation of stem cells for regenerative medicine and processing of protein gels for surgical wound care.
For nearly 20 years DHR International has been a leading, privately held provider of executive search solutions with 49 wholly-owned offices spanning the globe. DHR’s renowned consultants specialize in all industries and functions in order to provide unparalleled senior-level executive search, management assessment and succession planning services tailored to the unique qualities and specifications of our select client base. For more information on DHR International, visit http://www.dhrinternational.com.
312-782-1581 selias@dhrinternational.com
